SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy
Research
[키워드] adopted
AGPAT2
anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
association
asymptomatic patient
BSCL2
carried
Characteristics
chest pain
chi-square test
children
clinical
collected
Comorbidities
congenital
Congenital generalized lipodystrophy
coronavirus
COVID
COVID-19
cross-sectional
described
detectable
diabete
diabetes
diarrhea
died
evaluate
Fever
Fisher
flu-like symptoms
gaussian distribution
gene mutation
Generalized
groups
High dose
higher risk
Hospitalization
individual
Infection
insulin
insulin resistance
Lipodystrophy
malaise
Mann-Whitney U test
median age
medication
Nasopharyngeal swab
nausea
new strain
no difference
obesity
outcome
outcomes
Participants
Patient
patients
Pearson
positive individual
Prevalence
reactive
Result
RT-qPCR
SARS-CoV-2
SARS-COV-2 infection
severe metabolic
significance level
Spread
subject
triglycerides
variables
was used
were assessed
women
worse prognosis
[DOI] 10.1186/s13098-021-00680-1 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13098-021-00680-1 PMC 바로가기 [Article Type] Research